News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Julien Taieb: Genetic and transcriptomic analyses of early-onset colon cancer
Photo of Julein Taieb taken from esmo.org
Nov 11, 2024, 16:45

Julien Taieb: Genetic and transcriptomic analyses of early-onset colon cancer

Julien Taieb, Professor at Paris Descartes University, shared a post on LinkedIn:

”Colon cancer in adult <50 is increasing, we need to move forward in understanding molecular mechanisms underlying this epidemiological phenomenon.

We have published in our new journal ESMO GI oncology  a paper on ‘Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a post hoc analysis of 2973 patients from two adjuvant randomized trials’

Showing minimal differences in these patients as compared to older patients, but this is a first step and more efforts are needed to understand this new entity and find personalized therapeutic options for these patients.

Also follow the ENTERO forthcoming meeting dedicated to patients with EOCC.”

Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a post hoc analysis of 2973 patients from two adjuvant randomized trials

Authors: A. Gandini, C. Gallois, H. Blons, C. Mulot, N. Agueeff, C. Lepage, R. Guimbaud, L. Mineur, J. Desramé, B. Chibaudel, A. de Reyniés, T. André, P. Laurent-Puiq, J. Taieb.

Julien Taieb: Genetic and transcriptomic analyses of early-onset colon cancer

A. de Reyniès A. Gandini B. Chibaudel C. Gallois C. Lepage C. Mulot cancer early on set colon cancer EOCC epidemiological phenomenon ESMO GI oncology H. Blons J. Desramé J. Taieb Julien Taieb L. Mineur N. Agueeff OncoDaily Oncology P. Laurent-Puiq R. Guimbaud T. André
Special Coverage
Science
Jan 16, 2025, 14:16
Cecilia Pompili: Terrific paper from Dr Melinda L. Hsu on unmet needs and QoL in NSCLC survivors
Career
Jan 16, 2025, 14:12
St. Jude Global Critical Care team is looking for a Clinical Research Scientist
Career
Jan 16, 2025, 14:06
Antonio Gualberto: I’m starting a new position as Global Head, Due Diligence Oncology at EMD Serono
Blog
Jan 16, 2025, 13:56
Miriam Mutebi: Stories like Claire’s haunt us as clinicians
Blog
Jan 16, 2025, 13:39
NHS England starts sending bowel cancer screening tests to over-50s
Blog
Jan 16, 2025, 13:38
Justin Stebbing: Princess of Wales "in remission" from cancer
Career
Jan 16, 2025, 13:33
Daniel Mckenzie: Started my role at KidzCan Zimbabwe as an Executive Director
Science
Jan 16, 2025, 13:29
Chang-il Hwang: How organoid technology is transforming pancreatic cancer research
Blog
Jan 16, 2025, 13:22
Prisca Githuka: I rang the bell at the finish line after 10 years of being on Cancer hormonal treatment
Blog
Jan 16, 2025, 13:21
Akhil Santhosh: Prevention of dermatologically adverse events with amivantamab combinations
Radiotherapy
Jan 16, 2025, 13:14
What Is Palliative Radiotherapy and How It Works? Pros and Cons
Opinion
Jan 16, 2025, 13:08
Amol Akhade: OS difference in first line Cdk inhibitors plus AI, amongst Palbociclib, Ribociclib and abemaciclib in MBC